Abstract
A case of phenytoin-carbamazepine cross-sensitivity is presented. Similar signs and symptoms occurred during administration of both drugs. A common metabolic intermediate is offered as a possible explanation of the mechanism. Clinicians should be careful when choosing alternatives in patients with hypersensitivity reactions to anticonvulsants. Valproic acid may be the safest choice in this setting.
Get full access to this article
View all access options for this article.
References
1.
Haruda
H.
Phenytoin hypersensitivity: 38 cases. Neurology 1979 ; 29 : 1480 –5 .
2.
Josephs
SH
,
Rothman
SJ
,
Buckley
RH
. Phenytoin hypersensitivity. J Allergy Clin Immunol 1980 ; 66 : 166 –72 .
3.
Spielberg
SP
,
Gordon
GB
,
Blake
DA
,
Goldstein
DA
,
Her-Long
HF
. Predisposition to phenytoin hepatotoxicity assessed in vitro. N Engl J Med 1981 ; 305 : 722 –7 .
4.
Gerson
WT
,
Fine
DG
,
Spielberg
SP
,
Sensenbrenner
LL
. Anticonvulsant-induced aplastic anemia: increased susceptibility to toxic drug metabolites in vitro. Blood 1983 ; 61 : 889 –93 .
5.
Flowers
FP
,
Araujooe
. Phenytoin hypersensitivity syndrome. J Emerg Med 1987 ; 5 : 103 –8 .
6.
Schwinghammer
TL
,
Howrie
DL
. Phenytoin-induced lymph-adenopathy. Drug Intell Clin Pharm 1983 ; 17 : 460 –2 .
7.
Prosser
TR
,
Lander
RD
. Phenytoin induced hypersensitivity reactions. Clin Pharm 1987 ; 6 : 728 –34 .